Dr. Lampros Lamprogiannis is a pediatric ophthalmologist and scientific head of the Pediatric Ophthalmology department at the "Ophthalmica" Institute of Ophthalmology and Microsurgery in Thessaloniki. He was recently elected assistant professor at Aristotle University of Thessaloniki. He trained at Cambridge, King's College Hospital, and Great Ormond Street Hospital for Children, and in 2023 became the first Greek ophthalmologist to hold the European sub-specialty certification in Pediatric Ophthalmology and Strabismus (FEBO-SP). His research spans pediatric ophthalmology, amblyopia and strabismus, and nanotechnology applications such as drug-eluting intraocular lenses, and he has been a frequent presenter at national and European pediatric ophthalmology meetings.
The authors of a review of 16 gene therapy trials for inherited retinal diseases explain why the pediatric evidence base remains thin and argue that individual-level, age-stratified reporting is the change most needed before CRISPR-based editing reaches children.
